Robert Spratt
Internal Medicine · Youngstown, OHNPI 1578550554
Payments from drug & device makers
Across 213 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$441
- Boehringer Ingelheim$438
- Amarin Pharma, Inc.$364
- AbbVie$308
- Pfizer$300
- AstraZeneca$287
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $441 |
| Boehringer Ingelheim | 14 | $438 |
| Amarin Pharma, Inc. | 26 | $364 |
| AbbVie(2 entities) | 24 | $308 |
| Pfizer | 25 | $300 |
| AstraZeneca | 6 | $287 |
| Amgen | 9 | $223 |
| Johnson & Johnson | 16 | $217 |
| Merck | 17 | $192 |
| Kowa Pharmaceuticals America, Inc. | 7 | $113 |
| Ironwood Pharmaceuticals, Inc | 2 | $107 |
| Sanofi-aventis U.S. LLC | 7 | $105 |
| Novartis | 5 | $65 |
| Sanofi Pasteur Inc. | 4 | $64 |
| Lilly USA, LLC | 5 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Abbott | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 3 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Genentech USA, Inc. | 2 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,526 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $205 |
| Gabapentin | 12 | $80 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Youngstown
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
- Narinder SainiSpringfield$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.